NeuroMetrix, Inc.

NeuroMetrix, Inc. is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. Founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology, the company is headquartered in Woburn, MA. NeuroMetrix has three FDA cleared commercial products: DPNCheck®, a point-of-care test for detecting peripheral neuropathies, and Quell® Fibromyalgia, a wearable neurostimulation device for reducing the symptoms of fibromyalgia in adults. They also maintain an active R&D program focused on developing new and innovative medical devices utilizing non-invasive neurostimulation technology.

NeuroMetrix's business model revolves around developing novel medical devices that utilize a proprietary consumable, with the majority of their revenue generated by aftermarket sales of these consumables. The company is committed to solving unmet healthcare needs in the global neurology and pain markets through their expertise in neurotechnology and their mission to improve health through advances in the field.

NeuroMetrix is an innovation-driven company dedicated to improving health through neurotechnology. They focus on developing and commercializing non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. Their mission is to solve unmet healthcare needs in the global neurology and pain markets, creating meaningful innovations that benefit millions of people worldwide.

NeuroMetrix promotes a culture of innovation and collaboration. The company's commitment to advancing neurotechnology is evident in its active R&D program and its focus on developing non-invasive medical devices. This commitment is fostered by a team of dedicated professionals who work together to solve unmet healthcare needs in the worldwide neurology and pain markets. This shared goal of improving health through neurotechnology likely fosters a positive and supportive work environment.